NRC Stock Update: National Research Corp Shows Volatile Recovery Pattern

Price Movement Summary

• Recent Close: $13.43 (Nov 3) after bouncing from $11.28 low (Oct 10)
• 3-Month Range: $11.28 - $16.14 (-30% peak-to-trough)
• Key Catalyst: October 28 surge (+16% on 273k volume - 2.7x average)

Breaking Down the Action

1. August Strength Steady climb from $12.58 to $16.03 (27% gain) on average volume, peaking Sept 9.

2. September Breakdown Sharp 31% collapse from $16.03 to $11.48 over six weeks, accelerated by high-volume selling Sept 19 (-6.9%) and Sept 29 (-6.2%).

3. October Rebound October 28 explosion ($11.43→$13.25) marked strongest single-day gain since August. Subsequent consolidation between $12.62-$13.45 suggests new trading range forming.

Technical Positioning

• Bullish Signals: MACD crossover + volume surge confirm momentum shift
• Immediate Resistance: $13.45-13.62 area (recent highs & Bollinger upper band)
• Critical Support: $12.02-12.62 zone (October rebound base)
• Volume Profile: Sustained above-average trading since rebound (115k-141k vs 101k avg)

Fundamental Context

	Metric	Value	Implication
✅	ROE	66.9%	Exceptional capital efficiency
⚠️	Debt/Equity	559%	Highly leveraged structure
🔻	Revenue Growth	-3.4%	Contracting operations
📊	P/E	11.57	Below healthcare sector average

Strategic Considerations

For Active Traders

• Near-term upside to $13.62 (+1.4%) if momentum holds
• Stop-loss prudent below $12.75 (recent consolidation low)
• Watch for volume confirmation on breakout attempts

Longer-Term Investors

• High debt load raises sustainability questions
• Negative growth contrasts with strong ROE - warrants deeper due diligence
• Sector outlook for health analytics remains favorable despite company-specific risks

Recommended Action Plan

1. Day Traders: Scalp $13.15-13.45 range with tight stops
2. Swing Traders: Consider long positions above $13.30 targeting $13.62 exit
3. Risk-Averse Investors: Monitor debt management progress before entry

Data reflects market conditions as of November 3, 2025 closing. Past performance ≠ future results. Consult a financial advisor before trading. Volatility risk elevated with 52-week range of $9.76-$21.64.